Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of GFAP and UCH-L1 Biomarkers in Clinical Practice for the Management of Mild Traumatic Brain Injury

NCT07931066 is registered in ClinicalTrials.gov with University Hospital, Grenoble as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07931066 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of GFAP and UCH-L1 Biomarkers in Clinical Practice for the Management of Mild Traumatic Brain Injury
Lead sponsor
University Hospital, Grenoble
Phase
Observational
Overall status
Not yet recruiting
Start date
November 5, 2026
Completion date
July 30, 2027
Enrollment
800 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

biomarkers, mild traumatic brain injury (mtbi)

Arms

As registered; 1 arm.

  • All adult patients admitted in the Emergency Department for mild traumatic brain injury Follow-up telephone call after one month

    All adult patients presenting to the Grenoble Alpes University Hospital emergency department for mild traumatic brain injury will be enrolled and analyzed during the study period

Primary endpoints

Registered primary outcome measures; 1 primary.

  • The proportion of patients who underwent GFAP and UCH-L1 testing, and in whom a brain CT scan was avoided following a negative result in accordance with current guidelines 1 month

    The proportion of patients who underwent GFAP and UCH-L1 testing, and in whom a brain CT scan was avoided following a negative result in accordance with current guidelines

Lead sponsor's other trials

University Hospital, Grenoble, most recent start first.

Similar trials

Same condition (Brain Concussion) and phase, most recent start first.